Stage FocusSeed, Series A
GeographyUS, Global
TypeCVC
Last Activity2024
Industry Focus
Industries
MedTechBiotech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
Dexcom Ventures launched in February 2021 as the CVC arm of Dexcom, the $10B+ market cap leader in continuous glucose monitoring (CGM). Led by Jason Halac (MD) with over 20 years of combined team experience, the fund has made 9 targeted investments in biosensing technology and data-driven healthcare adjacent to Dexcom's CGM core. The portfolio is highly focused: Beta Bionics (iLet Bionic Pancreas)...
Notable Investments
B
Beta BionicsS
SignosN
NutromicsE
EpitelB
BiointelliSenseM
MedcryptSimilar Funds
Broadview Ventures
Boston, United States
DeepTech NativeMedTechBiotechSeedSeries A
Peregrine Ventures
Or Yehuda, Israel
DeepTech NativeMedTechBiotechNeurotechSeedSeries A
Pivotal Life Sciences
San Francisco, United States
DeepTech NativeMedTechBiotechSeedSeries A
Sagax Capital
GeneralistMedTechCybersecurity HardwareClimate TechSeedSeries A
Woori Venture Partners
Seoul, South Korea
GeneralistMedTechAI InfrastructureBiotechSeedSeries A
Boston Scientific Ventures
Marlborough, United States
GeneralistMedTechSeedSeries A